Source: White House
Photo / Image Source: Unsplash,
Today, the U.S. government is releasing the National COVID-19 Preparedness Plan – which will enable America to move forward safely, sustaining and building on the progress we’ve made over the past 13 months. This plan lays out the roadmap to help us fight COVID-19 in the future as we begin to get back to our more normal routines. We look to a future when Americans no longer fear lockdowns, shutdowns, and our kids not going to school. It’s a future when the country relies on the powerful layers of protection we have built and invests in the next generation of tools to stay ahead of this virus.
The President’s National COVID-19 Preparedness Plan focuses on four key goals: Protect Against and Treat Covid-19 Prepare for New Variants Prevent Economic and Educational Shutdowns Continue to Vaccinate the World Protect Against and Treat COVID-19 The United States has experienced five waves of the pandemic since 2020, including three in the past year that were driven by new variants. America experienced a wave of COVID-19 cases driven by the Alpha variant in early Spring 2021 – a time when the U.S. vaccination program was administering a record number of vaccines every day. The Delta variant, which was more than twice as contagious as the original coronavirus strain, then swept across the country starting in Summer 2021, beginning in the South and spreading to the Midwest and Rocky Mountain regions.
Omicron represented another step in the virus’s evolution, and has been one of the most contagious viruses in history, causing record numbers of infections around the world over the past three months. However, because of both lower severity of the Omicron variant and a stronger level of population immunity from vaccinations, Omicron has caused relatively fewer cases of severe COVID-19. Compared to prior waves of COVID-19 in the United States, the Omicron wave has had a lower proportion of cases resulting in hospitalization or death.
America has weathered the current Omicron wave with minimal disruption – schools and businesses largely remained open. As the country emerges from the Omicron wave, our path forward relies on maintaining and continually enhancing the numerous tools we now have to protect ourselves and our loved ones – from vaccines, to tests, to treatments, to masks, and more.
In January 2021, Americans had very few tools to protect against COVID-19, and the tools we did have were in limited supply. Over the last year, together, with states, localities, and public and private partners, the Administration has mobilized an unprecedented, whole-of-society effort to give Americans the tools they need to protect themselves.
The Administration has put vaccines at the center of our COVID-19 response because vaccines are the best tool we have to prevent hospitalization and death. We stood up the largest free vaccination program in our country’s history – mobilizing 90,000 vaccination locations, standing up dozens of federally-run mass vaccination sites with the ability to administer more than a combined 125,000 shots a day, and deploying over 9,000 federal personnel to support vaccinations nationwide – including over 5,000 active duty troops.
As a result, today, the vast majority of Americans have the protection of a vaccine – with 215 million Americans fully vaccinated, and an estimated two-thirds of eligible adults having received their booster shot. Vaccinated and boosted people are 41 times less like to die of COVID-19 than unvaccinated individuals. And America’s unprecedented vaccination campaign has saved lives: a December 2021 estimate suggested that vaccines saved over 1 million American lives and successfully prevented over 10 million hospitalizations.
The Administration has also expedited the development, manufacturing, and procurement of COVID-19 treatments, building a diverse medicine cabinet filled with more treatments now than at any point in the pandemic. Today about 4 million treatment courses are available to Americans, with 1 million additional courses of the Pfizer antiviral available in March, and another 2.5 million additional courses of the Pfizer antiviral available in April. In total, we have secured 20 million courses of Pfizer’s life-saving antiviral pills, which have been shown to reduce the risk of hospitalization or death by 89%.
The nation’s testing supply has increased dramatically. We now have free testing sites at 21,500 locations around the country. In January 2021, there were no rapid, at-home tests on the market available to Americans; during January 2022, there were more than 480 million at-home tests available to Americans on top of all other testing options. And we stood up COVIDtests.gov so Americans could order tests that shipped directly to their homes — for free. Private insurance and Medicaid now cover rapid at-home tests for free, and Medicare will fully cover these at-home tests starting this spring.
And the U.S. government has successfully put equity at the heart of a nationwide public health response. Hispanic, Black, and Asian adults are now vaccinated at the same rates as White adults. This is the result of an all-of-society effort that got America to where it is today: employers who offered paid time off for their employees; child care providers who offered drop-in services for caregivers to get vaccinated; public transit authorities and ride-sharing companies that provided free rides to vaccination sites; churches, civic organizations, barbershops, and beauty salons, who opened their doors to be trusted spaces for vaccinations; and the families who made vaccination a family affair.
The path forward in the fight against COVID-19 is clear: we must maintain and continually enhance the tools we have to protect against and treat COVID-19. The Administration looks forward to working with Congress to ensure that we have the resources to do just that. Because we have these tools, we can begin to get back to our more normal routines safely and the use of public health mitigation measures like masking can be less frequent. The Centers for Disease Control and Prevention (CDC) has updated its framework for recommendations on preventive measures like masking, so masks are recommended when and where they matter the most and Americans will be wearing masks less often.
Make no mistake, as America moves forward we will leave no one behind. Equity will remain at the very center of our path forward in the fight against COVID-19. And we will be there to support Americans with the long-term impacts of COVID-19, including people experiencing Long COVID or mental and behavioral health challenges; as well as families suffering from the tragedy of losing someone they loved.
The Administration will work with Congress to secure the necessary funding to: Launch an effort to vaccinate America’s youngest children as soon as the U.S. Food and Drug Administration (FDA) authorizes and the CDC recommends a vaccine for that age group. Ensure that Americans – of all ages – can get the protection of an effective vaccine. Increase American manufacturing capacity to reliably produce an additional 1 billion vaccine doses per year – three times the U.S. population – and accelerate research and development of a single COVID vaccine that protects against SARS-CoV-2 and all its variants, as well as previous SARS-origin viruses. Continue vaccination outreach and education efforts and combat misinformation and disinformation. Ensure there are enough treatments for every American who needs them. Launch a nationwide Test to Treat Initiative so Americans can rapidly access treatment, including by visiting a “one-stop” location to get a free test and free treatment pills. Update the framework for recommendations on preventive measures like masking to reflect the current state of the disease. Launch a one-stop-shop website that allows Americans to easily find public health guidance based on the COVID-19 risk in their local area and access tools to protect themselves. Sustain and increase American manufacturing of COVID-19 tests, so we can continue to have a robust supply of tests. Prioritize protections for the immunocompromised and take new actions to protect people with disabilities and older adults. Help Americans with the long-term impacts of COVID-19. Ensure equitable access to COVID-19 health care and public health resources. Prepare for New Variants As we work to keep ourselves protected against COVID-19, America must remain prepared for any new variant that may come our way. To do so, the Administration has developed a comprehensive plan for how we monitor this virus to stay ahead of it, adapt our tools swiftly to combat a new variant, and deploy emergency resources to help communities.
Before January 2021, the federal government had insufficient data and sequencing capabilities and was ill-equipped to respond to new variants. Electronic case reporting was in place for only a handful of states in 2020 and the country could sequence only 3,000 viral isolates per week. America had no plan for responding to a new variant or standing up comprehensive efforts to respond to a surge in COVID-19 cases.
The Administration has enhanced our collection, production, and analysis of data, and expanded electronic case reporting to all 50 states, Washington D.C., Puerto Rico, and thousands of health care facilities. The CDC now tracks a range of key COVID-19 response metrics including cases, tests, vaccinations, and hospital admissions in real-time.
Additionally, the CDC launched – and is continually enhancing – the National Wastewater Surveillance System (NWSS) to track the presence of SARS-COV-2 in wastewater samples collected across the country. And America has established a world-class sequencing operation, sequencing up to 90,000 isolates a week. The CDC’s sequencing efforts can now reliably detect variants that account for as little as 0.1% of all COVID-19 cases circulating in the United States. And when new variants are identified, the federal government has a network of researchers – federal, academic, and commercial – who are able to study the sequence and assess mutations rapidly, allowing the government to respond quickly to concerning variants.
The Administration has also successfully built a robust emergency response infrastructure. Our surge response – led by the Federal Emergency Management Agency (FEMA) and HHS – developed capabilities to stand up over 100 federal mass vaccination sites and federal surge testing sites; distribute millions of critical supplies; and deploy thousands of federal clinical and non-clinical personnel to support states, Tribes, and territories. Since July 2021, the federal government has deployed over 4,000 military and non-military personnel including doctors, nurses, and paramedics; sent over 3,400 ventilators, ambulances, and other critical supplies; and shipped over 115 million pieces of PPE. And over the last year, FEMA has invested $300 million in state hospital preparedness to expand hospital capacity in 38 states.
Moving forward, the Administration will maintain our proven data, sequencing, variant response, and surge response capabilities. The CDC will continue to improve COVID-19 data collection, reporting, and analysis so America is better informed and ready to respond to new variants. And if new variants emerge, the federal government will leverage established playbooks to assess a new variant’s impact on our vaccines, treatments, and tests, and rapidly deploy the tools, personnel, and resources Americans need. America will also retain a significant stockpile of tools to combat COVID-19 that remain ready for deployment.
Have you taken the vaccine? Were you mandated to? By whom?
Share the wealth of health with your friends and family by sharing this article with 3 people today.
If this article was helpful to you, donate to the Shidonna Raven Garden and Cook E-Magazine Today. Thank you in advance.